What's new

Zostavax: Product information as approved by the CHMP on 13 December 2012, pending endorsement by the European Commission

Zostavax: Product information as approved by the CHMP on 13 December 2012, pending endorsement by the European Commission

Jun 11, 2025 - 09:45
 0
Zostavax: Product information as approved by the CHMP on 13 December 2012, pending endorsement by the European Commission
Read More

Tags:

Previous Article

STAT+: RFK Jr.’s new chronic disease agency faces a road block: Congress

Next Article

EMEA-003481-PIP01-23

Related Posts

Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 11, 2025  0

Human medicines European public assessment report (EPAR): Pedmarqsi, sodium thiosulfate, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

EMEA-003443-PIP02-23

EMEA-003443-PIP02-23

Jun 10, 2025  0